• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·ZYDUSWELL.NS
Share

Zydus Wellness Limited Stocks

₹ 511.1Last Updated 24.08.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

₹ 1.63B

₹ 511.1
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free Natura, and Sugar Free Green. The company also offers well-known beverages like Complan, a milk-based health drink, and Glucon D, a glucose-infused refreshment, alongside Sugarlite, a unique blend of sugar and stevia. In the personal care segment, Zydus Wellness markets the Everyuth brand, featuring skincare items such as soap-free face washes, masks, scrubs, and cleansers. The Nycil brand provides solutions for prickly heat, cooling powders, and hand sanitizers. Furthermore, their Nutralite line includes a diverse array of spreads, from probiotic butter and table spreads to ghee, butter, cholesterol-fat-free spreads, mayonnaise, and chocolate spreads. Beyond its domestic operations in India, Zydus Wellness actively exports its offerings. Tracing its origins to 1988, the Ahmedabad, India-based entity was initially known as Carnation Nutra Analogue Foods Limited before adopting its current name, Zydus Wellness Limited, in January 2009. It operates as a subsidiary of Cadila Healthcare Limited.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of ZYDUSWELL.NS is 598 and suggests 21.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.08.2026 21:24

"Dollar for Dollar": Canada Announces $20 Billion in Retaliatory Tariffs Against the U.S.

25.08.2026 20:17

Billionaire Jack Ma bought $76 million worth of Alibaba stock. He supports the company's efforts in the AI sector.

25.08.2026 19:34

Wells Fargo double downgrades Canada Goose due to impact of El Nino

25.08.2026 18:47

Druckenmiller called the buying of long-term U.S. bonds a mistake that undermines confidence in the market

25.08.2026 18:05

The U.S. Is Aiming to Isolate Iran Trade-Wise: Which Countries Might Be Affected?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026